Tenderwize
Back to tender search

Open house drug discount agreements for active substance Interferon beta-1b, ATC L03AB08

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 222 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Interferon beta-1b, ATC L03AB08

60/100

Opportunity Score

PromisingLow complexity
SuppliesOpen
Why this score?

Opportunity

60 / 100

Complexity

30 / 100

Risk factors

Open house contracts can be replaced by exclusive contracts at any time, leading to automatic termination.

Initial submission deadline (April 30, 2025) is only 19 days after notice publication (April 11, 2025).

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Conclusion of non-exclusive discount agreements for Interferon beta-1b under open-house model
  • Contracts available to all interested pharmaceutical companies
Show full summary

Non-exclusive discount agreement ('Rabattvertrag') for the active substance Interferon beta-1b (ATC L03AB08) under an open-house model. All interested pharmaceutical companies meeting eligibility can join. Contracts run up to 24 months from June 1, 2025. Initial submission deadline for first contracts: April 30, 2025. No estimated value provided. The notice explicitly states it is not a public procurement under EU law; published for transparency only.

Risks

Open house contracts can be replaced by exclusive contracts at any time, leading to automatic termination.

Initial submission deadline (April 30, 2025) is only 19 days after notice publication (April 11, 2025).

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Proof of marketability via Lauer-Taxe listing or AMIce database extract

Eligibility

  • Only authorized and marketable medicines in Germany are eligible

Administrative

  • Submission of signed contract documents by specified deadlines

Requirements may be incomplete.

Buyer

Lots (1)

LOT-0001

Open house drug discount agreements for active substance Interferon beta-1b, ATC L03AB08

Conclusion of non-exclusive discount agreements for Interferon beta-1b under open-house model. All pharmaceutical companies can join under uniform conditions. Contracts are non-exclusive and may be replaced by exclusive agreements later. Maximum contract duration 24 months.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Procurement Details

Publication date
10 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
235668-2025

Documents (1)

Similar tenders